Drug Trial Radar · NCT03631771
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
Last checked: Nov 20, 2026Latest source record: Apr 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Mar 2022
Primary completion
Aug 2024
Study completion Feb 2025
Sponsor
- Lead sponsor
- GE HealthcareIndustry
- Sponsor type
- Industry
- Collaborators
- Bayer; Guerbet/Liebel-Flarsheim
- First posted
- Aug 15, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 3 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 4 multicenter prospective study to estimate the proportion of patients aged birth to 3 years who develop hypothyroidism within 6 months after receiving intravascular iohexol (Omnipaque™), iodixanol (Visipaque™), iopromide (Ultravist®), or ioversol (Optiray®) as the iodinated contrast medium (ICM) for clinical evaluation during an ICM-enhanced diagnostic imaging procedure.
Conditions
- Hypothyroidism
Interventions
IohexolDrug
Iohexol administered intravascularly
IodixanolDrug
Iodixanol administered intravascularly
IopromideDrug
Iopromide administered intravascularly
IoversolDrug
Ioversol administered intravascularly
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of subjects who develop hypothyroidism post-ICM.Time frame: 6 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.